This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
NOVEL EXPERIMENTAL PLATFORM FOR PRODOMAL PARKINSONS DISEASE Investments < €500k United States of America 2016
Airway protection deficits according to stimulus type in Parkinsons disease Investments < €500k United States of America 2016
Modifiers of C9orf72 associated dipeptide protein toxicity in a C. elegans model Investments < €500k United States of America 2016
Development of protein molecular probes for detection of alpha synuclein oligomeric assemblies Investments < €500k United States of America 2016
Neural Substrates of Deterministic Decision Making Investments < €500k United States of America 2016
Autophagy dysfunction in Parkinsons Disease by VPS35 D620N Investments < €500k United States of America 2016
Glial uptake of dopamine after L-DOPA medication Investments < €500k United States of America 2016
Pathogenic role of the novel mitochondrial apoptotic protein PSAP in ALS Investments < €500k United States of America 2016
Alpha-Galactosidase A: a novel target for reducing alpha-synuclein toxicity Investments < €500k United States of America 2016
Noninvasive High-resolution Pediatric Surface EMG Investments < €500k United States of America 2016
